Entrada Therapeutics Press Releases
Intracellular biologics drug delivery start-up Entrada launches with $59 million Entrada Therapeutics Nabs $59M for Drugs that Gain “Entry” to Cells Entrada emerges with $59M to fund the delivery of biologic therapies into the cell Entrada launches today, taking a $59M shot at some tough intracellular targets Boston biotech Entrada launches with $59M to tackle